Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Tuberous Sclerosis × Carbamazepine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Tuberous Sclerosis 1 Multiple Endocrine Neoplasia Type 1 1 Focal Cortical Dysplasia 1 Carcinoma, Non-Small-Cell Lung 1 Breast Neoplasms 1

Interventions

radiprodil 2 Sirolimus 2 exemestane 1 Melatonin 1 Itraconazole 1 Injections 1 Everolimus 1 Carbamazepine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06965881 2025-11-21

Study to Evaluate the Pharmacokinetics and Safety Effects Following Coadministration of Carbamazepine or Itraconazole With Radiprodil in Healthy Adults

GRIN Therapeutics, Inc.

Phase 1 Terminated

Focal Cortical Dysplasia, Tuberous Sclerosis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡